Charu Aggarwal
University of Pennsylvania

Last Updated On 11/17/2023 11:08:50 AM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.

Employment
No Relationships to Disclose

Leadership
No Relationships to Disclose

Stock and Other Ownership Interests
No Relationships to Disclose

Honoraria
No Relationships to Disclose

Consulting or Advisory Role
Company: Genentech
Recipient: You
Company: Lilly
Recipient: You
Company: Celgene
Recipient: You
Company: Merck
Recipient: You
Company: Astra Zeneca
Recipient: You
Company: Blueprint Genetics
Recipient: You
Company: Shionogi
Recipient: You
Company: Daiichi Sankyo/Astra Zeneca
Recipient: You
Company: Regeneron/ Sanofi
Recipient: You
Company: Eisai
Recipient: You
Company: BeiGene
Recipient: You
Company: Turning Point Therapeutics
Recipient: You
Company: Pfizer
Recipient: You
Company: Janssen
Recipient: You
Company: Boehringer Ingelheim
Recipient: You

Speakers' Bureau
Company: AstraZeneca
Recipient: An Immediate Family Member
Company: Roche/Genentech
Recipient: An Immediate Family Member

Research Funding
Company: Genentech/Roche
Recipient: Your Institution
Company: Incyte
Recipient: Your Institution
Company: Macrogenics
Recipient: Your Institution
Company: Merck Sharp & Dohme
Recipient: Your Institution
Company: AstraZeneca/MedImmune
Recipient: Your Institution

Patents, Royalties, Other Intellectual Property
No Relationships to Disclose

Expert Testimony
No Relationships to Disclose

Travel, Accommodations, Expenses
No Relationships to Disclose

Other Relationship
No Relationships to Disclose

(OPTIONAL) Uncompensated Relationships
No Relationships to Disclose

(OPTIONAL) Open Payments Link
No Relationships to Disclose